0108.HK HKSE
SR Medical Technology Company Limited
1W: +3.9%
1M: +24.1%
3M: +6.0%
YTD: -23.0%
1Y: +59.9%
3Y: +117.5%
5Y: +119.8%
HK$2.23 ($0.28)
+0.12 (+5.70%)
Weekly Expected Move ±11.0%
HK$2
HK$2
HK$2
HK$2
HK$3
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$80M
-23.0% ▼
5Y CAGR: +41.4%
Capital Expenditures
$1M
-18.9% ▼
5Y CAGR: -24.0%
Free Cash Flow
$79M
-23.4% ▼
5Y CAGR: +52.2%
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$112M
-157.7% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $15M | $75M | -$320M | -$129M | -$968M |
| Depreciation & Amort. | $5M | $4M | $3M | $3M | $2M |
| Stock-Based Comp. | $0 | $0 | $0 | $7M | $3M |
| Change in Working Capital | -$73M | -$24M | -$237M | -$53M | $26M |
| Other Non-Cash Items | $57M | -$8M | $375M | $277M | $1.0B |
| Operating Cash Flow | $4M | $48M | -$179M | $104M | $80M |
| — Investing Activities — | |||||
| Capital Expenditures | -$282K | -$638K | -$922K | -$537K | -$210K |
| Acquisitions (Net) | -$15M | $137M | -$753K | $0 | $11M |
| Investment Purchases | -$11M | -$138M | -$135M | -$31M | $0 |
| Investment Sales | $23M | $61M | $136M | $11M | $20M |
| Other Investing | $18M | $5M | -$136M | -$307M | -$23M |
| Investing Cash Flow | $15M | $64M | -$137M | -$327M | $8M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$143M | $2M | $818M | $300M | -$17M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $113M | -$45M | -$466M | -$126M | -$182M |
| Financing Cash Flow | -$31M | -$44M | $352M | $174M | -$199M |
| Net Change in Cash | -$12M | $70M | $49M | -$44M | -$112M |
| Cash End of Period | $196M | $304M | $354M | $306M | $193M |
| Free Cash Flow | -$87M | -$33M | -$180M | $103M | $79M |